Top Healthcare Stocks
Healthcare stocks were ending slightly lower this afternoon,
giving back small gains earlier in the session and with the NYSE
Healthcare Sector Index down 0.1% and shares of healthcare
companies in the S&P 500 also declining about 0.1% as a
In company news, RedHill Biopharma (
) was holding on to a better than 8% gain in late Tuesday trade,
with shares maintaining a perch within 20 cents of its session high
at $12.00 each after the company announcing a $2.5 million private
placement of stock and warrants with Broadfin Capital.
The clinical-stage drug-maker plans on using proceeds from the
financing for general working capital as well as ongoing research
and development, including work on its lead gastrointestinal
programs - RHB-104 for Crohn's disease and RHB-105 for H. pylori
Both prospective drugs are currently in Phase III testing.
In other sector news,
(+) QDEL, FDA grants 510(k) clearance for the company's AmpliVue
Group B Strep Assay, the company's non-instrumented molecular
diagnostic test for the virus carried by 10% to 30% of pregnant
women and causing sepsis and pneumonia in newborns.
(-) STSI, Confirms receipt of FDA warning letter about Anatabloc
and CigRx because the two consumer products contain anatabine, a
new dietary ingredient requiring premarket notification. Also
arranges $15 mln credit facility running through April 15 with
former CEO Jonnie Williams Sr.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.